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Abstract
Background:  Cystine/glutamate transporter, system xc-, contributes to the maintenance of
intracellular glutathione levels and the redox balance in the extracellular space. The main
component of the transporter, xCT, is known to be strongly induced by various stimuli like
oxidative stress in mammalian cultured cells. We examined the expression of xCT mRNA in vivo
in the experimental endotoxemia.
Methods: Northern blot analysis and in situ hybridization were used to investigate the expression
of xCT mRNA in the tissues of the mice exposed to bacterial lipopolysaccharide (LPS).
Results: Northern blot analysis revealed that xCT mRNA was constitutively expressed in the
brain, thymus, and spleen, and that the expression of xCT mRNA was strongly up-regulated in
thymus and spleen by the administration of a sublethal dose of LPS. In addition to brain, thymus,
and spleen, xCT mRNA was detected also in the bronchiolar epithelium of the lung by the
administration of the lethal dose of LPS.
Conclusion: xCT is induced in some specific tissues by the administration of LPS. The results
suggest that cystine/glutamate transporter plays an important role under the inflammatory
conditions.
Background
Sepsis is a severe disorder associated with high lethality in
men even under appropriate treatment with antibiotics
and complete eradication of bacteria. Lipopolysaccharide
(LPS)-induced endotoxemia is a well-established model
for infection with Gram-negative bacteria. LPS induces
symptoms such as fever, hypotension, disseminated intra-
vascular coagulation, and multiple organ system failure,
and thus mimics sepsis caused by bacteria. Recent studies
have indicated that distinct Toll-like receptors (TLR) are
the key molecules recognizing either Gram-negative or
Gram-positive bacteria [1]. LPS binds to TLR4 on leuko-
cytes, triggering a cascade of downstream events including
synthesis and release of cytokines like tumor necrosis
facter-a (TNF-a) and interleukins [2].
Cystine/glutamate transporter, designated system xc
-, is an
exchange agency for anionic amino acids with high specif-
icity for the anionic form of cystine and glutamate [3].
This transporter is known to contribute to the mainte-
nance of intracellular GSH levels in many types of mam-
malian cells in culture [4]. It has also been suggested that
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this transporter contributes to the maintenance of the
redox balance out of the cell [5]. Cystine/glutamate trans-
porter consists of two protein components, xCT and the
heavy chain of 4F2 antigen (4F2hc), whereas the transport
activity appears to be mediated by xCT [6]. The activity of
cystine/glutamate transporter is induced by various stim-
uli, including electrophilic agents like diethyl maleate,
oxygen, hydrogen peroxide, amino acid deprivation, TNF-
a, and LPS [7-9]. We have demonstrated that the induc-
tion of xCT mRNA by diethyl maleate is mediated through
the electrophile response element (EpRE) (also called
antioxidant response element). The EpRE is located in the
5' flanking region of xCT gene and activation of xCT gene
transcription involves the transcription factor nuclear fac-
tor-erythroid 2-related factor 2 (Nrf2), which binds to the
EpRE element [10].
xCT mRNA and the activity of cystine/glutamate trans-
porter is dramatically induced in mouse peritoneal mac-
rophages by LPS even at very low concentrations, similar
to that as observed in the plasma of patients with sepsis
[9]. Unlike diethyl maleate, LPS induction of xCT expres-
sion involves a different mechanism and is not mediated
by the EpRE [10]. We have shown that xCT mRNA is con-
stitutively expressed in specific regions of the brain [11],
but not in liver, heart, kidney, and lung [6]. Recent studies
indicated that xCT plays a pivotal role in the brain [12-15]
and immune system [16]. It has, however, remained enig-
matic whether LPS induces xCT expression also in vivo.
Therefore, we have investigated the effect of LPS on the
induction of xCT mRNA in mice under the pathological
conditions like sepsis. Our results show that xCT mRNA is
strongly up-regulated in thymus, spleen and lung in
response to LPS, suggesting that system xc
- plays an impor-
tant role under inflammatory conditions.
Methods
Materials and Animal protocols
Total RNA was isolated from C57BL/6J male mice aged at
8–12 weeks. LPS from S. typhosa (DIFCO Laboratories)
was resuspended in sterile saline. Endotoxemia was
induced by intraperitoneal injection of different doses of
LPS ranging from 0.05 to 160 mg/kg. The RNA probes for
mouse xCT, mouse 4F2hc, and mouse β-actin were digox-
igenin (DIG)-labeled by transcription from the linearized
plasmids using RNA-labeling mix (Roche) and T3/T7 RNA
polymerase (Stratagene).
The experimental procedures involving animals were
approved by the University of Tsukuba Animal Care and
Use Committee and were done in accordance with its
guidelines.
Northern blot analysis
Total RNA was extracted using Isogen (Nippon Gene,
Japan). The RNA was electrophoresed on a 1% agarose gel
in the presence of 2.2 M formaldehyde, transferred onto
positively charged nylon membrane (Roche), and hybrid-
ized with the DIG-labeled RNA probes in DIG Easy Hyb
(Roche) for 16 h at 68°C. The membranes were washed
twice for 5 min at room temperature with 1 × SSC, 0.1%
SDS and then washed twice for 15 min at 68°C with 0.1 ×
SSC, 0.1% SDS. The hybridized bands were visualized
using CDP-Star (Roche).
In situ hybridization
The expression of xCT mRNA in the tissues was detected
by  in situ hybridization as described previously [11].
Briefly, mice were anesthetized with sodium pentobarbi-
tal (20 mg/kg, i.p.), perfused, and fixed with 4% parafor-
maldehyde in phosphate-buffered saline (PBS), pH 7.4.
The tissues were excised and post-fixed in the same fixa-
tive overnight. Then, the tissues were incubated in 30%
sucrose in PBS overnight and embedded with optimal cut-
ting temperature compound (Sakura Finetechnical Co.,
Ltd., Tokyo, Japan). Sections (10 µm) were cut in a cryo-
stat. The slides were placed in PBS containing 0.1% Tween
20 (PBT) at room temperature twice for 5 min and then
incubated in PBT containing 1 mg/ml proteinase K at
37°C for 5 min. The slides were rinsed in PBT three times,
fixed with 4% paraformaldehyde, rinsed in PBT three
times, and incubated with hybridization buffer (50% for-
mamide, 5 × SSC, pH 4.5, 1% SDS, 50 µg/ml heparin, and
50  µg/ml yeast RNA). After the addition of the DIG-
labeled probe (1000 ng/ml), slides were hybridized at
65°C overnight. Slides were rinsed in 50% formamide, 5
× SSC, pH4.5, 1% SDS at 65°C for 30 min, in 50% forma-
mide, 2 × SSC at 65°C for three times for 30 min each, and
in 25 mM Tris-HCl, pH 7.5, 0.8% NaCl, 0.02% KCl, 0.1%
Tween 20 (TBST) at room temperature three times for 5
min each. Slides were submerged in the blocking buffer
[0.5% blocking reagent (Roche) in TBST] at room temper-
ature for 1 hr and then incubated in sheep anti-DIG anti-
body conjugated to alkaline phosphatase in the blocking
buffer at 4°C overnight. Then, the slides were rinsed and
developed in the dark in BM purple alkaline phosphatase
substrate solution (Roche) containing 2 mM levamisole
for 2 days.
Results
To examine basal and inducible expression of the mouse
xCT gene in vivo, C57BL/6J mice were injected intraperi-
toneally either with saline or with saline containing LPS
(0.5 mg/kg body weight). Total RNA was extracted from
mice tissues and analyzed by Northern blotting with
mouse xCT and 4F2hc DIG-labeled RNA probes. Results
from a representative animal are shown in Fig. 1. In the
control mouse (saline injection), the xCT mRNA wasJournal of Inflammation 2007, 4:20 http://www.journal-inflammation.com/content/4/1/20
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detected in brain, thymus, and spleen, but not in lung,
heart, liver, and kidney. LPS administration significantly
increased the expression of xCT mRNA in thymus and
spleen. The constitutive expression of xCT mRNA in the
brain was faintly increased by LPS. To investigate the
kinetics of xCT mRNA up-regulation in thymus and
spleen, mice were injected intraperitoneally with LPS (0.5
mg/kg), and at the given time points, tissues were
removed and total RNA was analyzed by Northern blot-
ting (Fig. 2). The expression of xCT mRNA in thymus
gradually increased and was highest at 8 and 20 hours
after LPS injection. By contrast, in spleen the maximum
expression of xCT mRNA was reached already 3 hours
after LPS administration. Next, a dose dependency on the
expression of xCT mRNA was examined. As shown in Fig.
3, the induction of xCT mRNA in thymus was enhanced
with increasing doses of LPS It is noteworthy that the ratio
of smaller transcripts (2.5 and 3.5 kbp) to total transcripts
was substantially increased in thymus by injection of a
dose of 5 mg/kg, which is approximately one fourth of
LD50 of this kind of LPS. Similar results were obtained in
spleen, although the extent of the induction by LPS was
much weaker. While the expression of 4F2hc mRNA was
scarcely affected by LPS administration in thymus, it was
significantly enhanced by LPS in spleen.
We investigated the effect of the lethal dose of LPS (160
mg/kg) on the expression of xCT in tissues (Fig. 4). In thy-
mus and spleen, strong hybridization signals of xCT
mRNA were detected by injection of the lethal dose of
LPS. Besides these tissues, a strong signal of xCT mRNA
was also detected in lung under these conditions.
Since specific antibodies to xCT for immunohistochemis-
try have not been available yet, the expression of xCT in
the tissues was detected by in situ hybridization analysis.
The hybridization signals of xCT mRNA were very faint in
the thymus and spleen of mice injected even with the sub-
lethal dose of LPS (data not shown). Thus, we performed
in situ hybridization analyses in the tissues from the mice
injected the lethal dose of LPS (160 mg/kg). Under these
conditions, the signal of xCT mRNA was greatly aug-
mented in thymus (Fig. 5) and particularly strong signals
for xCT mRNA were detected in the cortex of this tissue.
Similarly, the signal of xCT mRNA was strongly increased
in the white pulp of spleen (Fig. 6). In addition, strong sig-
nals of xCT mRNA were detected exclusively in the bron-
chiolar epithelium of lung in the mice injected with the
lethal dose of LPS (Fig. 7).
Discussion
In the present study, we have detected constitutive expres-
sion of xCT mRNA in thymus and spleen in addition to
brain [11], and found that LPS is a potent inducer of xCT
gene expression in vivo. After administration of sublethal
doses of LPS, expression of xCT mRNA was significantly
increased in thymus and spleen in a dose-dependent man-
ner. The expression of xCT mRNA was further enhanced
by a lethal dose of LPS, and in situ hybridization revealed
that this expression was mainly confined to the cortex of
Time course of expression of xCT and 4F2hc mRNA in thy- mus and spleen of the mice injected with LPS Figure 2
Time course of expression of xCT and 4F2hc mRNA 
in thymus and spleen of the mice injected with LPS. 
Mice were intraperitoneally injected with 0.5 mg/kg LPS, and 
thymus and spleen were isolated at the indicated time points. 
Total RNA was extracted and Northern blot analysis was 
performed using DIG-labeled RNA probes.
Tissue distribution of xCT and 4F2hc mRNA in mice injected  with or without LPS Figure 1
Tissue distribution of xCT and 4F2hc mRNA in mice 
injected with or without LPS. Mice were intraperito-
neally injected with saline (-) or LPS 0.5 mg/kg LPS (+), and 
tissues were isolated 8 h after administration. Total RNA was 
extracted and Northern blot analysis was performed using 
DIG-labeled RNA probes.Journal of Inflammation 2007, 4:20 http://www.journal-inflammation.com/content/4/1/20
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Expression of xCT mRNA in spleen of the mice injected with  a lethal dose of LPS by nonisotopic in situ hybridization Figure 6
Expression of xCT mRNA in spleen of the mice 
injected with a lethal dose of LPS by nonisotopic in 
situ hybridization. Mice were intraperitoneally injected 
with saline (A, B) or 160 mg/kg (C, D), and the spleen was 
isolated after 8 h. Adjacent sections were hybridized with 
DIG-labeled antisense (A, C) or sense (B, D) probes for xCT. 
Magnifications: ×50.
Expression of xCT mRNA in thymus, spleen and lung of the  mice injected with lethal dose of LPS by Northern blot analy- sis Figure 4
Expression of xCT mRNA in thymus, spleen and lung 
of the mice injected with lethal dose of LPS by 
Northern blot analysis. Mice were intraperitoneally 
injected with saline, 0.5, or 160 mg/kg LPS, and the tissues 
were isolated 5 h after administration. Total RNA was 
extracted and Northern blot analysis was performed using 
DIG-labeled RNA probes.
Dose-dependent expression of xCT and 4F2hc mRNA in  thymus and spleen of the mice injected with LPS Figure 3
Dose-dependent expression of xCT and 4F2hc 
mRNA in thymus and spleen of the mice injected 
with LPS. Mice were intraperitoneally injected with LPS at 
the dose indicated, and thymus and spleen were isolated 
after 8 h. Total RNA was extracted and Northern blot analy-
sis was performed using DIG-labeled RNA probes.
Expression of xCT mRNA in thymus of the mice injected  with a lethal dose of LPS by nonisotopic in situ hybridization Figure 5
Expression of xCT mRNA in thymus of the mice 
injected with a lethal dose of LPS by nonisotopic in 
situ hybridization. Mice were intraperitoneally injected 
with saline (A, B) or 160 mg/kg (C, D), and the thymus was 
isolated after 8 h. Adjacent sections were hybridized with 
DIG-labeled antisense (A, C) or sense (B, D) probes for xCT. 
Magnifications: ×50.Journal of Inflammation 2007, 4:20 http://www.journal-inflammation.com/content/4/1/20
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thymus and to the white pulp of spleen. Under these con-
ditions, we also found that xCT mRNA is massively
induced in the bronchial epithelium of the lung.
Mammalian cultured cells expressing xCT transport extra-
cellular cystine via system xc
-, and reduce it to cysteine,
which is in turn used for the synthesis of GSH and pro-
teins. A fraction of cysteine is released from cells via neu-
tral amino acid transporters, and the cysteine is rapidly
oxidized to cystine. Thus, a series of these transporters and
redox reactions constitutes the cystine/cysteine cycle
across the plasma membrane [5]. We have demonstrated
previously that spleen lymphocytes have hardly detecta-
ble activity of system xc
- regardless of the activation by LPS
in vitro [17]. The supply of cysteine for GSH synthesis in
lymphocytes may depend on the vicinal cells expressing
the activity of system xc
- and releasing cysteine via the cys-
tine/cysteine cycle into these tissues. Malmezat et al. [18]
have reported that the requirement for cysteine is
increased in some tissues including spleen during the
acute phase of sepsis in rats. GSH synthesis rates are signif-
icantly increased in spleen and thymus during the acute
phase of sepsis in rats [19] or by LPS administration [20].
The increased GSH synthesis accounts for the enhanced
utilization of cysteine at least in part. Thus, the induction
of xCT by LPS in spleen may contribute to the supply of
cysteine to the lymphocytes by the vicinal cells, although
we cannot rule out the possibility that the activity of sys-
tem xc- is induced in the lymphocytes in vivo.
The activity of system xc
-  sustains the cystine/cysteine
cycle, and thus maintains the redox balance between cys-
tine and cysteine in cultured cells [5]. In sepsis patients,
the levels of most amino acids in plasma were found to be
decreased by 10–30%, whereas cystine and phenylalanine
were significantly elevated [21]. Administration of LPS is
decreased plasma GSH level [20,22]. We have shown
recently that xCT-deficient mice display a significant
increase in plasma concentration of cystine and decrease
in plasma concentration of GSH, resulting in the oxidative
shift towards cystine in the plasma cystine/cysteine ratio
[23]. These observations suggest that the organs like thy-
mus and spleen, where xCT is constitutively expressed,
contribute to the clearance of cystine in plasma. As a
result, xCT may contribute to ameliorating the oxidative
shift caused by LPS and maintaining the plasma redox bal-
ance. Recent studies have demonstrated that the cystine/
cysteine redox balance is associated with aging and
proatherogenic events [24,25]. The induction of xCT in
vivo may contribute to restoring the plasma redox balance
under septic conditions.
The role of glutamate receptors in synaptic transmission
and excitotoxicity have been mainly studied in the central
nervous system. However, recent evidence points to simi-
lar glutamate receptors function also in various other
organs, including thymus [26]. System xc
- is an exchange
agency, and the anionic form of cystine is transported in
exchange for glutamate with a molar ratio of 1:1 [4]. Thus,
the induction of xCT by LPS causes the release of gluta-
mate when cystine is taken up via system xc
- in thymus.
Recently, Pacheco, et al., have demonstrated that gluta-
mate released via system xc
- expressed in dendritic cells is
a highly effective regulator in the initiation of T cell-medi-
ated immune response [16]. Metabotropic glutamate
receptors are expressed in mouse thymocytes and thymic
stromal cells [27]. Although we have not identified which
types of cells express xCT mRNA in thymus in the present
study, the glutamate released via system xc
- into the micro-
environment of thymus by the cells expressing xCT might
function to activate the glutamate receptors of the cells
during T cell maturation and/or proliferation in thymus.
The significance of glutamate released via system xc
- in the
immune tissues should be further explored.
Endotoxin induces a whole-body inflammatory response
that in turn mediates organ damage. The lung is known to
be one of the target organs in which failure is usually
apparent. Intense cellular infiltration (predominantly
neutrophils) of the interstitium and bronchiolar walls by
LPS administration has been reported [28,29]. We have
Expression of xCT mRNA in lung of the mice injected with a  lethal dose of LPS by nonisotopic in situ hybridization Figure 7
Expression of xCT mRNA in lung of the mice 
injected with a lethal dose of LPS by nonisotopic in 
situ hybridization. Mice were intraperitoneally injected 
with saline (C) or 160 mg/kg (A, B, D), and lung tissue was 
isolated after 8 h. Adjacent sections were hybridized with 
DIG-labeled antisense (A-C) or sense (D) probes for xCT. B 
is a magnification of the boxed region in A. Magnifications: 
×50 (A, C, D); ×200 (B).Journal of Inflammation 2007, 4:20 http://www.journal-inflammation.com/content/4/1/20
Page 6 of 7
(page number not for citation purposes)
recently demonstrated that the peritoneal exudate neu-
trophils express xCT mRNA and harbour system xc
- activity
[30]. It is likely that not only the bronchiolar epithelium
but also flammatory cells such as neutrophils infiltrated
into the bronchiolar walls by LPS administration express
xCT mRNA in these areas (Fig. 7). Thimmulappa et al.
[31] showed that disruption of Nrf2 dramatically
increased the mortality of mice in response to LPS and
that the administration of LPS resulted in greater lung
inflammation in Nrf2-deficient mice. Their data suggest
that Nrf2 regulates the innate immune response during
sepsis and improves survival by maintaining redox home-
ostasis by regulating GSH levels and other antioxidant
enzymes through Nrf2. The induction of xCT gene by the
stimuli like electrophilic agents is regulated by Nrf2 [10].
However, it has also been demonstrated that induction of
xCT by LPS is observed even in Nrf2-deficient mice [32],
indicating that the expression of xCT may be mediated
through not only Nrf2-dependent but also Nrf2-inde-
pendent signaling pathways. The activity of system xc
- is
significantly induced by oxygen in human fibroblasts
derived from fetal lung [5]. Induction of xCT in lung may
be partially responsible for alleviating LPS-induced
inflammation by maintaining GSH level.
The results of the present study suggest that the induction
of xCT in vivo under the inflammatory conditions may be
important to maintain the redox balance in plasma and to
supply cysteine for GSH synthesis via the cystine/cysteine
cycle to cells, such as lymphocytes. Very recently, Kaleeba
and Berger [33] have reported that xCT serves as a fusion-
entry receptor for Kaposi's sarcoma-associated herpesvi-
rus. The susceptibility towards infection by this virus may
be increased in inflamed tissues where xCT is induced. We
expect to gain more insights into the physiological role of
xCT under septic conditions in vivo by using xCT null
mice.
Conclusion
The administration of LPS strongly up-regulates expres-
sion of xCT mRNA in the tissues like thymus, spleen, and
lung. The increased expression of xCT in response to LPS
may imply a specific requirement for these tissues to resist
oxidative stress conditions caused by LPS and may con-
tribute to ameliorating organ damages in endotoxemia.
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